Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125497812 | 12549781 | 2 | F | 20160714 | 20160712 | 20160729 | EXP | DK-HQ SPECIALTY-DK-2016INT000464 | INTERCHEM | BERGMANN TK, FILPPULA AM, LAUNIAINEN T, NIELSEN F, BACKMAN JT, BROSEN K. NEUROTOXICITY AND LOW PACLITAXEL CLEARANCE ASSOCIATED WITH CONCOMITANT CLOPIDOGREL THERAPY IN A 60-YEAR-OLD CAUCASIAN WOMAN WITH OVARIAN CARCINOMA. BR J CLIN PHARMACOL. 2016;81(2):313-315 | 60.00 | YR | F | Y | 0.00000 | 20160729 | OT | DK | DK |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125497812 | 12549781 | 1 | PS | PACLITAXEL. | PACLITAXEL | 1 | 175 MG/M2, 3HR CONSTANT INFUSION, 4 CYCLES | 20262 | 175 | MG/M**2 | |||||||||
| 125497812 | 12549781 | 2 | SS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 3 | C | CARBOPLATIN. | CARBOPLATIN | 1 | 5-6 MG/MIN/ML, EVERY THIRD WEEK | U | 0 | ||||||||||
| 125497812 | 12549781 | 4 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 5 | C | ONDANSETRON | ONDANSETRON | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 6 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 8 | C | SALICYLIC ACID. | SALICYLIC ACID | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 9 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 10 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 11 | C | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 12 | C | TRAMADOL. | TRAMADOL | 1 | UNK | U | 0 | ||||||||||
| 125497812 | 12549781 | 13 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125497812 | 12549781 | 1 | Ovarian cancer |
| 125497812 | 12549781 | 2 | Product used for unknown indication |
| 125497812 | 12549781 | 3 | Ovarian cancer |
| 125497812 | 12549781 | 4 | Product used for unknown indication |
| 125497812 | 12549781 | 5 | Product used for unknown indication |
| 125497812 | 12549781 | 6 | Product used for unknown indication |
| 125497812 | 12549781 | 7 | Product used for unknown indication |
| 125497812 | 12549781 | 8 | Product used for unknown indication |
| 125497812 | 12549781 | 9 | Product used for unknown indication |
| 125497812 | 12549781 | 10 | Product used for unknown indication |
| 125497812 | 12549781 | 11 | Product used for unknown indication |
| 125497812 | 12549781 | 12 | Product used for unknown indication |
| 125497812 | 12549781 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125497812 | 12549781 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125497812 | 12549781 | Drug interaction | |
| 125497812 | 12549781 | Nausea | |
| 125497812 | 12549781 | Neuropathy peripheral | |
| 125497812 | 12549781 | Toxicity to various agents | |
| 125497812 | 12549781 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |